No benefit of hydroxychloroquine on SARS-CoV-2 viral load reduction in non-critical hospitalized patients with COVID-19

{ 'indexed': {'date-parts': [[2023, 4, 3]], 'date-time': '2023-04-03T12:19:29Z', 'timestamp': 1680524369647}, 'reference-count': 18, 'publisher': 'Springer Science and Business Media LLC', 'issue': '4', 'license': [ { 'start': { 'date-parts': [[2020, 10, 27]], 'date-time': '2020-10-27T00:00:00Z', 'timestamp': 1603756800000}, 'content-version': 'tdm', 'delay-in-days': 0, 'URL': 'https://www.springer.com/tdm'}, { 'start': { 'date-parts': [[2020, 10, 27]], 'date-time': '2020-10-27T00:00:00Z', 'timestamp': 1603756800000}, 'content-version': 'vor', 'delay-in-days': 0, 'URL': 'https://www.springer.com/tdm'}], 'content-domain': {'domain': ['link.springer.com'], 'crossmark-restriction': False}, 'published-print': {'date-parts': [[2020, 12]]}, 'DOI': '10.1007/s42770-020-00395-x', 'type': 'journal-article', 'created': { 'date-parts': [[2020, 10, 27]], 'date-time': '2020-10-27T20:13:55Z', 'timestamp': 1603829635000}, 'page': '1765-1769', 'update-policy': 'http://dx.doi.org/10.1007/springer_crossmark_policy', 'source': 'Crossref', 'is-referenced-by-count': 4, 'title': 'No benefit of hydroxychloroquine on SARS-CoV-2 viral load reduction in non-critical hospitalized ' 'patients with COVID-19', 'prefix': '10.1007', 'volume': '51', 'author': [ { 'ORCID': 'http://orcid.org/0000-0003-2071-0061', 'authenticated-orcid': False, 'given': 'Klinger Soares', 'family': 'Faíco-Filho', 'sequence': 'first', 'affiliation': []}, {'given': 'Danielle Dias', 'family': 'Conte', 'sequence': 'additional', 'affiliation': []}, { 'given': 'Luciano Kleber', 'family': 'de Souza Luna', 'sequence': 'additional', 'affiliation': []}, { 'given': 'Joseane Mayara Almeida', 'family': 'Carvalho', 'sequence': 'additional', 'affiliation': []}, {'given': 'Ana Helena Sitta', 'family': 'Perosa', 'sequence': 'additional', 'affiliation': []}, {'given': 'Nancy', 'family': 'Bellei', 'sequence': 'additional', 'affiliation': []}], 'member': '297', 'published-online': {'date-parts': [[2020, 10, 27]]}, 'reference': [ { 'key': '395_CR1', 'unstructured': 'WHO(2020). Coronavirus disease 2019 (COVID-19), Situation Report – 51. ' 'World Health Organization'}, { 'key': '395_CR2', 'doi-asserted-by': 'publisher', 'first-page': '101663', 'DOI': '10.1016/j.tmaid.2020.101663', 'volume': '34', 'author': 'P Gautret', 'year': '2020', 'unstructured': 'Gautret P, Lagier JC, Parola P, Hoang VT, Meddeb L, Sevestre J, Mailhe ' 'M, Doudier B, Aubry C, Amrane S, Seng P, Hocquart M, Eldin C, Finance J, ' 'Vieira VE, Tissot-Dupont HT, Honoré S, Stein A, Million M, Colson P, la ' 'Scola B, Veit V, Jacquier A, Deharo JC, Drancourt M, Fournier PE, Rolain ' 'JM, Brouqui P, Raoult D (2020) Clinical and microbiological effect of a ' 'combination of hydroxychloroquine and azithromycin in 80 COVID-19 ' 'patients with at least a six-day follow up: a pilot observational study. ' 'Travel Med Infect Dis 34:101663', 'journal-title': 'Travel Med Infect Dis'}, { 'key': '395_CR3', 'doi-asserted-by': 'publisher', 'first-page': '814', 'DOI': '10.1002/jmv.25801', 'volume': '92', 'author': 'P Luo', 'year': '2020', 'unstructured': 'Luo P, Liu Y, Qiu L, Liu X, Liu D, Li J (2020) Tocilizumab treatment in ' 'COVID-19: a single center experience. J Med Virol 92:814–818', 'journal-title': 'J Med Virol'}, { 'key': '395_CR4', 'doi-asserted-by': 'publisher', 'first-page': '10970', 'DOI': '10.1073/pnas.2005615117', 'volume': '117', 'author': 'X Xu', 'year': '2020', 'unstructured': 'Xu X, Han M, Li T, Sun W, Wang D, Fu B, Zhou Y, Zheng X, Yang Y, Li X, ' 'Zhang X, Pan A, Wei H (2020) Effective treatment of severe COVID-19 ' 'patients with tocilizumab. Proc Natl Acad Sci U S A 117:10970–10975', 'journal-title': 'Proc Natl Acad Sci U S A'}, { 'key': '395_CR5', 'doi-asserted-by': 'publisher', 'first-page': '269', 'DOI': '10.1038/s41422-020-0282-0', 'volume': '30', 'author': 'M Wang', 'year': '2020', 'unstructured': 'Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, Shi Z, Hu Z, Zhong W, Xiao ' 'G (2020) Remdesivir and chloroquine effectively inhibit the recently ' 'emerged novel coronavirus (2019-nCoV) in vitro. Cell Res 30:269–271', 'journal-title': 'Cell Res'}, { 'key': '395_CR6', 'doi-asserted-by': 'publisher', 'first-page': '1020', 'DOI': '10.1111/jth.14821', 'volume': '18', 'author': 'J Thachil', 'year': '2020', 'unstructured': 'Thachil J (2020) The versatile heparin in COVID-19. J Thromb Haemost ' '18:1020–1022', 'journal-title': 'J Thromb Haemost'}, { 'key': '395_CR7', 'doi-asserted-by': 'publisher', 'first-page': '67', 'DOI': '10.1016/S1473-3099(06)70361-9', 'volume': '6', 'author': 'A Savarino', 'year': '2006', 'unstructured': 'Savarino A, Di Trani L, Donatelli I, Cauda R, Cassone A (2006) New ' 'insights into the antiviral effects of chloroquine. Lancet Infect Dis ' '6:67–69', 'journal-title': 'Lancet Infect Dis'}, { 'key': '395_CR8', 'doi-asserted-by': 'publisher', 'first-page': '300', 'DOI': '10.1038/cr.2012.165', 'volume': '23', 'author': 'Y Yan', 'year': '2013', 'unstructured': 'Yan Y, Zou Z, Sun Y, Li X, Xu KF, Wei Y, Jin N, Jiang C (2013) ' 'Anti-malaria drug chloroquine is highly effective in treating avian ' 'influenza A H5N1 virus infection in an animal model. Cell Res 23:300–302', 'journal-title': 'Cell Res'}, { 'key': '395_CR9', 'doi-asserted-by': 'publisher', 'first-page': '104228', 'DOI': '10.1016/j.micpath.2020.104228', 'volume': '145', 'author': 'J Andreani', 'year': '2020', 'unstructured': 'Andreani J, Le Bideau M, Duflot I, Jardot P, Rolland C, Boxberger M et ' 'al (2020) In vitro testing of combined hydroxychloroquine and ' 'azithromycin on SARS-CoV-2 shows synergistic effect. Microb Pathog ' '145:104228', 'journal-title': 'Microb Pathog'}, { 'key': '395_CR10', 'doi-asserted-by': 'publisher', 'first-page': '732', 'DOI': '10.1093/cid/ciaa237', 'volume': '71', 'author': 'X Yao', 'year': '2020', 'unstructured': 'Yao X, Ye F, Zhang M, Cui C, Huang B, Niu P, Liu X, Zhao L, Dong E, Song ' 'C, Zhan S, Lu R, Li H, Tan W, Liu D (2020) In vitro antiviral activity ' 'and projection of optimized dosing design of hydroxychloroquine for the ' 'treatment of severe acute respiratory syndrome coronavirus 2 ' '(SARS-CoV-2). Clin Infect Dis 71:732–739', 'journal-title': 'Clin Infect Dis'}, { 'key': '395_CR11', 'doi-asserted-by': 'publisher', 'first-page': '2411', 'DOI': '10.1056/NEJMoa2012410', 'volume': '382', 'author': 'J Geleris', 'year': '2020', 'unstructured': 'Geleris J, Sun Y, Platt J, Zucker J, Baldwin M, Hripcsak G et al (2020) ' 'Observational study of hydroxychloroquine in hospitalized patients with ' 'Covid-19. N Engl J Med 382:2411–2418', 'journal-title': 'N Engl J Med'}, { 'key': '395_CR12', 'doi-asserted-by': 'publisher', 'first-page': 'm2263', 'DOI': '10.1136/bmj.m2263', 'volume': '369', 'author': 'I Torjesen', 'year': '2020', 'unstructured': 'Torjesen I (2020) Covid-19: Hydroxychloroquine does not benefit ' 'hospitalised patients, UK trial finds. BMJ: British Medical Journal ' '(Online) 369:m2263', 'journal-title': 'BMJ: British Medical Journal'}, { 'key': '395_CR13', 'unstructured': 'CDC. (2020) CDC 2019-Novel Coronavirus (2019-nCoV) Real-time RT-PCR ' 'diagnostic panel. Centers for Disease Control and Prevention'}, { 'key': '395_CR14', 'doi-asserted-by': 'publisher', 'DOI': '10.3346/jkms.2020.35.e79', 'volume': '35', 'author': 'J Lim', 'year': '2020', 'unstructured': 'Lim J, Jeon S, Shin HY, Kim MJ, Seong YM, Lee WJ, Choe KW, Kang YM, Lee ' 'B, Park SJ (2020) Case of the index patient who caused tertiary ' 'transmission of COVID-19 infection in Korea: the application of ' 'lopinavir/ritonavir for the treatment of COVID-19 infected pneumonia ' 'monitored by quantitative RT-PCR. J Korean Med Sci 35:e79', 'journal-title': 'J Korean Med Sci'}, { 'key': '395_CR15', 'doi-asserted-by': 'publisher', 'first-page': 'm1443', 'DOI': '10.1136/bmj.m1443', 'volume': '369', 'author': 'S Zheng', 'year': '2020', 'unstructured': 'Zheng S, Fan J, Yu F, Feng B, Lou B, Zou Q et al (2020) Viral load ' 'dynamics and disease severity in patients infected with SARS-CoV-2 in ' 'Zhejiang province, China, January-March 2020: retrospective cohort ' 'study. BMJ. 369:m1443', 'journal-title': 'BMJ.'}, { 'key': '395_CR16', 'doi-asserted-by': 'publisher', 'first-page': '1177', 'DOI': '10.1056/NEJMc2001737', 'volume': '382', 'author': 'L Zou', 'year': '2020', 'unstructured': 'Zou L, Ruan F, Huang M, Liang L, Huang H, Hong Z, Yu J, Kang M, Song Y, ' 'Xia J, Guo Q, Song T, He J, Yen HL, Peiris M, Wu J (2020) SARS-CoV-2 ' 'viral load in upper respiratory specimens of infected patients. N Engl J ' 'Med 382:1177–1179', 'journal-title': 'N Engl J Med'}, { 'key': '395_CR17', 'doi-asserted-by': 'publisher', 'first-page': '697', 'DOI': '10.1016/S1473-3099(20)30200-0', 'volume': '20', 'author': 'FX Lescure', 'year': '2020', 'unstructured': 'Lescure FX, Bouadma L, Nguyen D, Parisey M, Wicky PH, Behillil S, ' 'Gaymard A, Bouscambert-Duchamp M, Donati F, le Hingrat Q, Enouf V, ' 'Houhou-Fidouh N, Valette M, Mailles A, Lucet JC, Mentre F, Duval X, ' 'Descamps D, Malvy D, Timsit JF, Lina B, van-der-Werf S, Yazdanpanah Y ' '(2020) Clinical and virological data of the first cases of COVID-19 in ' 'Europe: a case series. Lancet Infect Dis 20:697–706', 'journal-title': 'Lancet Infect Dis'}, { 'key': '395_CR18', 'doi-asserted-by': 'publisher', 'first-page': '656', 'DOI': '10.1016/S1473-3099(20)30232-2', 'volume': '20', 'author': 'Y Liu', 'year': '2020', 'unstructured': 'Liu Y, Yan LM, Wan L, Xiang TX, Le A, Liu JM et al (2020) Viral dynamics ' 'in mild and severe cases of COVID-19. Lancet Infect Dis 20:656–657', 'journal-title': 'Lancet Infect Dis'}], 'container-title': 'Brazilian Journal of Microbiology', 'original-title': [], 'language': 'en', 'link': [ { 'URL': 'https://link.springer.com/content/pdf/10.1007/s42770-020-00395-x.pdf', 'content-type': 'application/pdf', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://link.springer.com/article/10.1007/s42770-020-00395-x/fulltext.html', 'content-type': 'text/html', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://link.springer.com/content/pdf/10.1007/s42770-020-00395-x.pdf', 'content-type': 'application/pdf', 'content-version': 'vor', 'intended-application': 'similarity-checking'}], 'deposited': { 'date-parts': [[2021, 10, 26]], 'date-time': '2021-10-26T23:15:35Z', 'timestamp': 1635290135000}, 'score': 1, 'resource': {'primary': {'URL': 'https://link.springer.com/10.1007/s42770-020-00395-x'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2020, 10, 27]]}, 'references-count': 18, 'journal-issue': {'issue': '4', 'published-print': {'date-parts': [[2020, 12]]}}, 'alternative-id': ['395'], 'URL': 'http://dx.doi.org/10.1007/s42770-020-00395-x', 'relation': {}, 'ISSN': ['1517-8382', '1678-4405'], 'subject': [ 'Microbiology', 'Computer Networks and Communications', 'Hardware and Architecture', 'Software'], 'container-title-short': 'Braz J Microbiol', 'published': {'date-parts': [[2020, 10, 27]]}, 'assertion': [ { 'value': '4 August 2020', 'order': 1, 'name': 'received', 'label': 'Received', 'group': {'name': 'ArticleHistory', 'label': 'Article History'}}, { 'value': '21 October 2020', 'order': 2, 'name': 'accepted', 'label': 'Accepted', 'group': {'name': 'ArticleHistory', 'label': 'Article History'}}, { 'value': '27 October 2020', 'order': 3, 'name': 'first_online', 'label': 'First Online', 'group': {'name': 'ArticleHistory', 'label': 'Article History'}}, { 'value': 'This content has been made available to all.', 'name': 'free', 'label': 'Free to read'}]}